RADEK SKODA to Leukemia, Myelogenous, Chronic, BCR-ABL Positive
This is a "connection" page, showing publications RADEK SKODA has written about Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
Connection Strength
0.617
-
Complex subclone structure that responds differentially to therapy in a patient with essential thrombocythemia and chronic myeloid leukemia. Blood. 2013 Nov 21; 122(22):3694-6.
Score: 0.410
-
BCR-ABL1-positive CML and BCR-ABL1-negative chronic myeloproliferative disorders: some common and contrasting features. Leukemia. 2008 Nov; 22(11):1975-89.
Score: 0.072
-
Chronic myeloproliferative disorders--introduction. Semin Hematol. 2005 Oct; 42(4):181-3.
Score: 0.058
-
A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med. 2005 Apr 28; 352(17):1779-90.
Score: 0.057
-
Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics. Nat Rev Clin Oncol. 2009 Nov; 6(11):627-37.
Score: 0.019